Efficacy and Safety of DIGNICAP™ System
NCT03712696
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
139
Enrollment
OTHER
Sponsor class
Conditions
Breast Cancer
Chemotherapy-induced Alopecia
Interventions
DEVICE:
DIGNICAP™
Sponsor
European Institute of Oncology